#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Sarcoidosis Acute myeloid leukaemia recurrent Adrenogenital syndrome Primary adrenal insufficiency Depression Dementia Non-small cell lung cancer Epstein-Barr virus infection Glioma Breast angiosarcoma Congenital pseudarthrosis Hyperinsulinism Leber's congenital amaurosis KBG syndrome Spina bifida More trials…

    Learn about Rare Diseases

    Nephroblastoma – Trials in Disease Rhabdoid tumour Synovial sarcoma recurrent – Treatment Haemolytic uraemic syndrome – Treatment Malignant fibrous histiocytoma – Treatment Haemophilia A without inhibitors – Life with Disease Small intestine leiomyosarcoma – Trials in Disease Leukoencephalopathy – Diagnostics Nephrotic syndrome – Diagnostics Lymphangiosarcoma – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Fluvastatin Davutamig Gallium (68Ga) Cilastatin Carbamazepine Mps-200 Ganciclovir Sodium Teplizumab Autologous Microfat Atorvastatin Calcium Ioflupane (123I) GSKVX000000025896 Xanthum Gum Hydroxocobalamin Nelivaptan Betula Alba Pollen Extract Magnesium Sulfate Baclofen Catequentinib Dihydrochloride Rbd5044 Sodium More therapies…

    Learn about Your Condition

    Invasive breast carcinoma Embolism venous Endometrial cancer stage I Latent tuberculosis Varices oesophageal Haemodynamic instability Small intestine leiomyosarcoma Phaeochromocytoma Colon cancer metastatic Propionic acidaemia Alveolar proteinosis Atrial fibrillation Microscopic polyangiitis Ophthalmoplegia Transitional cell carcinoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • A study of mezigdomide, carfilzomib, and dexamethasone in patients with relapsed or refractory multiple myeloma.

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma refractory
    Investigated Drugs:
    • Mezigdomide
    • Carfilzomib
    • Dexamethasone
    France

  • Comparison of sevoflurane and propofol for general anesthesia in patients with acute ischemic stroke undergoing mechanical thrombectomy

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Ischaemic stroke
    Investigated Drugs:
    • Sevoflurane
    • Propofol
    Spain

  • A study to evaluate the effectiveness of bleomycin sulfate for treating patients with low-flow vascular malformations using electrosclerotherapy.

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Vascular malformation
    Investigated Drugs:
    • Bleomycin Sulfate Ph. Eur.
    Slovenia

  • Comparison of standard dosing and blood level monitoring of abiraterone acetate for patients with metastatic castration-resistant prostate cancer

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Hormone-refractory prostate cancer
    Investigated Drugs:
    • Abiraterone Acetate
    The Netherlands

  • Using fludeoxyglucose (18F) in PET/CT imaging to diagnose and monitor cardiovascular device infections

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Device related infection
    Investigated Drugs:
    • Fludeoxyglucose (18F)
    Spain

  • Study of the distribution of cefazolin in the chest area of children undergoing heart surgery to prevent infection.

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Cefazolin
    France
Previous Page
1 … 726 727 728 729 730 … 1,657
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!